Integrative Approaches in Cancer Management: Bridging Herbal and Modern Medicinal Systems

Abstract

Cancer is among the leading causes of millions of deaths worldwide every year, even though much progress has been made in medicine and many studies are still underway to improve cancer therapy. Significant strides in cancer (oncological) research are directed toward discovering novel and efficient therapies aimed at mitigating the severe side effects induced by conventional treatments, incorporating a fusion of herbal and allopathic-based therapeutic approaches. Herbal-origin medicines play a pivotal role in this endeavor, offering potential solutions that combine the inherent benefits of natural compounds with the rigorously tested methodologies of modern medicine. By integrating herbal remedies into conventional oncological treatments, researchers seek to leverage their diverse pharmacological properties to enhance treatment efficacy while minimizing adverse effects. This integrative approach underscores a commitment to holistic patient care, striving to optimize outcomes and improve the overall quality of life for individuals undergoing cancer treatment.

Shogaol, Allicin, Apigenin, Baicalein, Baicalin, Curcumin, Quercetin, Emblica Officinalis, and Camptothecin could be a ray of hope for managing cancer. Advancements in the development of biocompatible materials have significantly contributed to both diagnostic and therapeutic purposes in cancer treatment. This includes targeted therapy, immunotherapy, and gene therapy. This review comprehensively examines recent innovations within both herbal and allopathic medicinal systems, specifically focusing on their utilization in cancer management. By analyzing the integration of these two medical paradigms, the review sheds light on promising strategies for effectively combating cancer while minimizing adverse effects. This exploration underscores the potential of combining traditional herbal remedies with modern allopathic approaches to optimize patient outcomes and pave the way for more personalized and comprehensive cancer care.